Suki
Last reviewed
Jun 8, 2026
Sources
14 citations
Review status
Source-backed
Revision
v1 · 1,444 words
Improve this article
Add missing citations, update stale details, or suggest a clearer explanation.
Suggest edit
CtrlK
Last reviewed
Jun 8, 2026
Sources
14 citations
Review status
Source-backed
Revision
v1 · 1,444 words
Add missing citations, update stale details, or suggest a clearer explanation.
Suki is an American healthcare AI company that builds an AI-powered voice assistant for clinicians. Its flagship product, the Suki Assistant, performs ambient clinical intelligence: it listens to patient visits and automatically drafts the clinical note, while also handling dictation, medical coding suggestions, order generation, and clinical question answering. The company is headquartered in Redwood City, California, and was founded in 2017 by Punit Soni and Karthik Rajan [1][2].
Suki is one of the most prominent independent vendors in the rapidly growing ambient documentation, or "AI scribe," market, where it competes with Abridge, Ambience Healthcare, Nabla, Commure, and the incumbent Microsoft Nuance Dragon Ambient eXperience (DAX) Copilot. By late 2024 the company reported partnerships with more than 300 health systems and clinics and said it had grown roughly fourfold over the prior 12 months [2][3][4]. In addition to its end-user Assistant, Suki sells Suki Platform, a software development kit (SDK) and set of APIs that lets electronic health record (EHR) vendors and other health technology companies embed Suki's voice and ambient AI into their own applications [5][6].
Suki was founded in 2017 in Redwood City, California, and originally operated under the name Robin AI before adopting the Suki brand [7]. Its co-founder and chief executive officer is Punit Soni, a product and technology executive who previously spent several years at Google, served as vice president of product at Motorola Mobility, and was chief product officer at the Indian e-commerce company Flipkart before starting the company [1][7]. The other co-founder, Karthik Rajan, brought an engineering and infrastructure background from prior roles at companies including Oracle and Salesforce [1].
Soni has described Suki's mission as making "healthcare invisible and assistive" by removing the administrative burden that contributes to clinician burnout, and he framed the voice assistant as a way to let doctors focus on patients rather than paperwork [2][7]. He has also said the company has "no plans for a traditional exit," positioning Suki as an independent long-term player rather than an acquisition target [3].
Suki's core offering is the Suki Assistant, a voice-enabled digital assistant that supports clinicians across several administrative tasks. It can operate in an ambient mode, listening to the natural conversation during a patient encounter and generating a structured clinical note, and it also supports traditional dictation. Beyond note creation, the Assistant offers medical coding support (including suggesting ICD-10 codes), patient summarization, and a question-answering capability that lets clinicians retrieve information by voice [2][4][7].
The Assistant is designed to write its output back into the clinician's system of record. Suki advertises deep, bidirectional integrations with the major EHRs used in the United States, including Epic, Oracle Health (formerly Cerner), athenahealth, and MEDITECH [5][8]. In April 2025 Suki announced an ambient order generation feature that stages prescription and other orders directly from the visit conversation, allowing clinicians to voice an order during the encounter and have Suki structure and code it; the capability rolled out first to athenahealth users with planned expansion to Epic, Oracle Health, and MEDITECH [9].
The company publishes efficiency claims for the Assistant that should be read as vendor figures rather than independent measurements: it has cited documentation generated roughly 72 percent faster on average and a return on investment of up to nine times within the first year of use [9].
The second product line is Suki Platform, an SDK and API suite that lets other healthcare technology vendors embed Suki's voice and ambient AI into their own products across iOS, Android, and web. Partners can incorporate capabilities such as ambient documentation, dictation, multilingual support, and voice-driven form filling. athenahealth, for example, integrated Suki's SDK and APIs into its athenaOne application so that clinicians can use Suki's ambient features without leaving the EHR [5][6]. Suki has also extended its technology to adjacent settings, including a January 2025 collaboration to surface Suki-generated clinical notes inside Zoom's Workplace for Clinicians offering, and an October 2025 nursing consortium, formed with members including McLeod Health, Citizens Memorial, Boone Health, and Fisher-Titus, to develop a version of the product for nurses [10][4].
Suki has raised approximately $165 million across its venture rounds, a figure the company cited at the time of its 2024 Series D; some later trackers and the company's own subsequent statements place cumulative funding at roughly $168 million after additional strategic investment [2][3][10]. The investor base has included Venrock, First Round Capital, Social Capital, Flare Capital, March Capital, Breyer Capital, inHealth Ventures, Hedosophia, and Zoom Ventures, along with individual backers such as Salesforce co-founder Marc Benioff [1][2][3].
The table below summarizes Suki's primary funding rounds. Round-level figures are drawn from company announcements and contemporaneous trade press; some early-round details vary slightly across sources and are noted accordingly.
| Round | Date | Amount | Lead investor(s) |
|---|---|---|---|
| Seed / Series A | May 2018 | ~$20 million (reported as a $5M seed plus a $15M Series A) | Venrock [1][11] |
| Series B | March 2020 | $20 million | Flare Capital [12] |
| Series C | December 2021 | $55 million | March Capital (with Philips Ventures) [13] |
| Series D | October 2024 | $70 million | Hedosophia [2][3] |
| Strategic | January 2025 | Undisclosed | Zoom Ventures [10] |
The $70 million Series D, announced on October 10, 2024, was led by Hedosophia with a substantial investment from Venrock and participation from existing backers March Capital, Flare Capital, Breyer Capital, and inHealth Ventures. Suki said the round brought its total funding to roughly $165 million and that it would use the capital for new product development and to support its sales and marketing growth [2][3][4]. The Series D was announced alongside an expanded strategic partnership with MedStar Health, which served as both a customer and a development collaborator [2].
Suki operates in the ambient clinical documentation market, a segment that expanded sharply after generative AI made it practical to draft a complete clinical note from a recorded conversation. The category is anchored by Microsoft, whose acquisition of Nuance brought it the Dragon Ambient eXperience (DAX) Copilot product, and is contested by a cohort of well-funded startups [2][14].
Among independent competitors, Abridge is the most heavily capitalized: it raised a $250 million Series D in February 2025 at a reported valuation of about $2.75 billion [14]. Ambience Healthcare, backed by Kleiner Perkins and OpenAI's startup fund, is another direct rival, as are Nabla, Commure, Heidi Health, and Suki's own Suki Platform partners and competitors. Relative to pure ambient scribes, Suki positions itself as "voice first," emphasizing that the Assistant not only transcribes but also accepts voice commands for ordering, charting, navigation, and clinical questions, a heritage that traces back to its origins as a voice-driven dictation assistant before it added ambient note generation [4][7].
A significant strategic dynamic for the entire market is the role of Epic, the dominant U.S. EHR vendor, which has built native AI scribe functionality and partnered with some scribe vendors; moves by Epic can meaningfully reshape demand for third-party documentation tools, representing both a distribution channel and a competitive threat for companies such as Suki [8][14]. Even so, Suki's combination of an established Assistant product, deep EHR integrations, an embeddable Platform business, and reported fourfold annual growth has kept it among the leading independent players in ambient clinical documentation [2][4][10].